LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 90.74 | 17.25 | 10809 | 6109 | 1.7692 | 1.1394 | MN20160310_N02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 92.71 | 17.25 | 43 | 6184 | 0.0070 | 0.1136 | MN20160310_N02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 92.71 | 17.25 | 11609 | 6184 | 1.8772 | 1.1541 | MN20160310_N02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 92.71 | 17.25 | 7930 | 6184 | 1.2823 | 1.0595 | MN20160310_N02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 92.71 | 17.25 | 11052 | 6184 | 1.7872 | 1.1416 | MN20160310_N02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 94.68 | 17.25 | 22 | 6239 | 0.0035 | 0.0290 | MN20160310_N02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 94.68 | 17.25 | 11964 | 6239 | 1.9175 | 1.1592 | MN20160310_N02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 94.68 | 17.25 | 6753 | 6239 | 1.0823 | 1.0187 | MN20160310_N02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 94.68 | 17.25 | 11396 | 6239 | 1.8265 | 1.1469 | MN20160310_N02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | G13 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 3.06 | 17.25 | 243 | 143 | 1.6968 | 1.3781 | MN20160310_N02 | G13 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | K07 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 3.06 | 17.25 | 223 | 143 | 1.5571 | 1.3121 | MN20160310_N02 | K07 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | N12 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 3.06 | 17.25 | 446 | 143 | 3.1142 | 1.9014 | MN20160310_N02 | N12 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | G13 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 5.03 | 17.25 | 464 | 273 | 1.6974 | 1.2839 | MN20160310_N02 | G13 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | K07 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 5.03 | 17.25 | 429 | 273 | 1.5694 | 1.2394 | MN20160310_N02 | K07 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | N12 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 5.03 | 17.25 | 773 | 273 | 2.8278 | 1.5959 | MN20160310_N02 | N12 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | G13 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 7.01 | 17.25 | 679 | 389 | 1.7433 | 1.2631 | MN20160310_N02 | G13 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | K07 |
MCF 10A-H2B-mCherry | Trametinib | 0.003 | 7.01 | 17.25 | 866 | 389 | 2.2234 | 1.3889 | MN20160310_N02 | K07 |